Regeneron Pharmaceuticals, Inc. (REGN)
782.38
-9.78
(-1.23%)
USD |
NASDAQ |
Feb 19, 16:00
780.00
-2.38
(-0.30%)
After-Hours: 20:00
Regeneron Pharmaceuticals Research and Development Expense (Quarterly) : 1.481B for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 2.151B |
| Gilead Sciences, Inc. | 1.565B |
| Johnson & Johnson | 4.268B |
| Eli Lilly & Co. | 3.802B |
| Merck & Co., Inc. | 3.992B |